Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
067630.KQ Stock Summary
Top 10 Correlated ETFs
067630.KQ
In the News
067630.KQ Financial details
Company Rating
Buy
Market Cap
1739.11B
Income
-5.98B
Revenue
97.99B
Book val./share
2267.55
Cash/share
763.02
Dividend
-
Dividend %
-
Employees
26
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-22.81
Forward P/E
-
PEG
2.56
P/S
8.83
P/B
4.48
P/C
21.32
P/FCF
-23.4
Quick Ratio
2.15
Current Ratio
2.63
Debt / Equity
0.72
LT Debt / Equity
0.22
-
-
EPS (TTM)
-58.74
EPS next Y
-
EPS next Q
-
EPS this Y
-89.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-2.98%
Revenue Q/Q
7.81%
EPS Q/Q
-139.55%
-
-
-
-
SMA20
-8.67%
SMA50
23.23%
SMA100
80.77%
Inst Own
-
Inst Trans
-
ROA
-11%
ROE
-18%
ROC
-0.06%
Gross Margin
-2%
Oper. Margin
-20%
Profit Margin
-39%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8260.0-25000.0
52W High
-34.92%
52W Low
+96.97%
RSI
45
Rel Volume
0.22
Avg Volume
4.23M
Volume
931.65K
Perf Week
2.33%
Perf Month
11.67%
Perf Quarter
80.98%
Perf Half Y
71.99%
-
-
-
-
Beta
0.462495
-
-
Volatility
300.62%, 2501.62%
Prev Close
-2.57%
Price
16270
Change
-2.22%
067630.KQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.23K | 927.21 | 538.47 | 986.34 | 962.77 | |
Net income per share | 80.81 | -563.59 | -494.76 | -537.56 | -58.79 | |
Operating cash flow per share | -133.12 | 20.3 | -141.77 | -294.58 | -98.41 | |
Free cash flow per share | -299.52 | -189.88 | -168.04 | -410 | -309.87 | |
Cash per share | 1.89K | 1.6K | 1.41K | 1.3K | 763.03 | |
Book value per share | 3.59K | 2.9K | 2.48K | 2.32K | 2.27K | |
Tangible book value per share | 2.56K | 2.11K | 1.85K | 1.22K | 1.72K | |
Share holders equity per share | 3.59K | 2.9K | 2.48K | 2.32K | 2.27K | |
Interest debt per share | 208.13 | 133.54 | 54.6 | 1.55K | 1.85K | |
Market cap | 1605.28B | 1707.81B | 1236.84B | 1039.99B | 1164.37B | |
Enterprise value | 1580.48B | 1682.04B | 1210.2B | 1156.49B | 1314.17B | |
P/E ratio | 213.46 | -30.61 | -25.16 | -19.16 | -194.6 | |
Price to sales ratio | 14.08 | 18.6 | 23.12 | 10.44 | 11.88 | |
POCF ratio | -129.59 | 849.64 | -87.82 | -34.96 | -116.25 | |
PFCF ratio | -57.59 | -90.85 | -74.09 | -25.12 | -36.92 | |
P/B Ratio | 4.81 | 5.95 | 5.02 | 4.43 | 5.04 | |
PTB ratio | 4.81 | 5.95 | 5.02 | 4.43 | 5.04 | |
EV to sales | 13.86 | 18.32 | 22.62 | 11.61 | 13.41 | |
Enterprise value over EBITDA | -454.77 | -260.54 | -74.43 | -77.21 | -73.76 | |
EV to operating cash flow | -127.58 | 836.82 | -85.93 | -38.88 | -131.21 | |
EV to free cash flow | -56.7 | -89.48 | -72.49 | -27.94 | -41.67 | |
Earnings yield | 0 | -0.03 | -0.04 | -0.05 | -0.01 | |
Free cash flow yield | -0.02 | -0.01 | -0.01 | -0.04 | -0.03 | |
Debt to equity | 0.04 | 0.04 | 0.02 | 0.62 | 0.72 | |
Debt to assets | 0.03 | 0.03 | 0.02 | 0.36 | 0.39 | |
Net debt to EBITDA | 7.13 | 3.99 | 1.64 | -7.78 | -8.41 | |
Current ratio | 5.61 | 10.15 | 11.59 | 6 | 1.09 | |
Interest coverage | -0.7 | -3.8 | -14.59 | -2.02 | -1.18 | |
Income quality | -1.65 | -0.04 | 0.29 | 0.55 | 1.67 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | -0.01 | 0 | -0.26 | |
Sales general and administrative to revenue | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.01 | 0.02 | 0.07 | 0.04 | 0.06 | |
Intangibles to total assets | 0.24 | 0.24 | 0.23 | 0.28 | 0.13 | |
Capex to operating cash flow | 1.25 | -10.35 | 0.19 | 0.39 | 2.15 | |
Capex to revenue | -0.14 | -0.23 | -0.05 | -0.12 | -0.22 | |
Capex to depreciation | -8.14 | -13.32 | -1.26 | -2.34 | -2.8 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.55K | 6.06K | 5.25K | 5.3K | 1.73K | |
ROIC | -0.01 | -0.03 | -0.07 | -0.05 | -0.06 | |
Return on tangible assets | 0.02 | -0.23 | -0.24 | -0.18 | -0.02 | |
Graham Net | 1.5K | 1.36K | 1.29K | -252.18 | -983.58 | |
Working capital | 183.82B | 163.46B | 143.29B | 133.99B | 11.59B | |
Tangible asset value | 238.07B | 208.51B | 183.8B | 122.71B | 175.41B | |
Net current asset value | 153.16B | 141.88B | 132.63B | -14.95B | -45.24B | |
Invested capital | 0.04 | 0.04 | 0.02 | 0.62 | 0.72 | |
Average receivables | 36.13B | 30.26B | 17.28B | 16.27B | 16.85B | |
Average payables | 24.77B | 16.14B | 7.91B | 9.83B | 7.27B | |
Average inventory | 6.5B | 4.62B | 1.93B | 6.32B | 8.07B | |
Days sales outstanding | 130.12 | 79.01 | 100.2 | 65.42 | 59.02 | |
Days payables outstanding | 90.4 | 22.41 | 62.75 | 32.88 | 18.56 | |
Days of inventory on hand | 24.18 | 8.41 | 10.8 | 38.08 | 18.95 | |
Receivables turnover | 2.81 | 4.62 | 3.64 | 5.58 | 6.18 | |
Payables turnover | 4.04 | 16.29 | 5.82 | 11.1 | 19.66 | |
Inventory turnover | 15.09 | 43.4 | 33.8 | 9.58 | 19.27 | |
ROE | 0.02 | -0.19 | -0.2 | -0.23 | -0.03 | |
Capex per share | -166.41 | -210.18 | -26.27 | -115.42 | -211.46 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 270.15 | 306.34 | 210.57 | 214.62 | 231.38 | |
Net income per share | -609.29 | 134.26 | -96.1 | -160.29 | 63.39 | |
Operating cash flow per share | -110.07 | 34.89 | -53.21 | -38.25 | -41.82 | |
Free cash flow per share | -165.08 | 0.26 | -93.78 | -84.44 | -131.92 | |
Cash per share | 1.29K | 1.5K | 426.63 | 708.56 | 763.02 | |
Book value per share | 2.31K | 2.44K | 2.33K | 2.21K | 2.27K | |
Tangible book value per share | 1.21K | 1.56K | 1.45K | 1.31K | 1.72K | |
Share holders equity per share | 2.31K | 2.44K | 2.33K | 2.21K | 2.27K | |
Interest debt per share | 1.49K | 1.54K | 1.58K | 1.71K | 1.74K | |
Market cap | 1047.66B | 1109.95B | 1032.94B | 933.34B | 1164.39B | |
Enterprise value | 1164.16B | 1231.63B | 1156.62B | 1077.58B | 1314.2B | |
P/E ratio | -4.23 | 20.31 | -26.4 | -14.3 | 45.11 | |
Price to sales ratio | 38.13 | 35.61 | 48.2 | 42.73 | 49.44 | |
POCF ratio | -93.58 | 312.74 | -190.74 | -239.74 | -273.54 | |
PFCF ratio | -62.4 | 41.8K | -108.24 | -108.59 | -86.72 | |
P/B Ratio | 4.46 | 4.47 | 4.36 | 4.16 | 5.05 | |
PTB ratio | 4.46 | 4.47 | 4.36 | 4.16 | 5.05 | |
EV to sales | 42.37 | 39.52 | 53.97 | 49.33 | 55.8 | |
Enterprise value over EBITDA | -180.43 | -1.32K | -251.33 | -239.96 | -190.38 | |
EV to operating cash flow | -103.98 | 347.02 | -213.58 | -276.79 | -308.74 | |
EV to free cash flow | -69.33 | 46.38K | -121.2 | -125.38 | -97.88 | |
Earnings yield | -0.06 | 0.01 | -0.01 | -0.02 | 0.01 | |
Free cash flow yield | -0.02 | 0 | -0.01 | -0.01 | -0.01 | |
Debt to equity | 0.62 | 0.61 | 0.66 | 0.74 | 0.72 | |
Debt to assets | 0.36 | 0.35 | 0.37 | 0.4 | 0.39 | |
Net debt to EBITDA | -18.06 | -130.69 | -26.87 | -32.12 | -21.7 | |
Current ratio | 6 | 6.53 | 2.69 | 3 | 1.09 | |
Interest coverage | -1.87 | -0.58 | -1.25 | -0.92 | -0.8 | |
Income quality | 0.18 | 0.26 | 0.55 | 0.24 | -0.66 | |
Dividend Yield | 0.09 | 0 | 0 | 0 | 0 | |
Payout ratio | -1.58 | 0.05 | -0.01 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.02 | 0.02 | 0 | |
Research and developement to revenue | 0.06 | 0.03 | 0.06 | 0.04 | 0.1 | |
Intangibles to total assets | 0.28 | 0.21 | 0.22 | 0.22 | 0.13 | |
Capex to operating cash flow | 0.5 | -0.99 | 0.76 | 1.21 | 2.15 | |
Capex to revenue | -0.2 | -0.11 | -0.19 | -0.22 | -0.39 | |
Capex to depreciation | -2.5 | -1.8 | -2.01 | -2.43 | -5.23 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.62K | 2.72K | 2.24K | 2.82K | 1.8K | |
ROIC | -0.02 | -0.01 | -0.02 | -0.02 | -0.02 | |
Return on tangible assets | -0.21 | 0.04 | -0.03 | -0.05 | 0.02 | |
Graham Net | -250.33 | -125.04 | -1.2K | -1.02K | -983.56 | |
Working capital | 133.99B | 146.9B | 40.53B | 64.48B | 11.59B | |
Tangible asset value | 122.71B | 158.7B | 147.81B | 133.41B | 175.41B | |
Net current asset value | -14.95B | -3.4B | -112.3B | -92.87B | -45.24B | |
Invested capital | 0.62 | 0.61 | 0.66 | 0.74 | 0.72 | |
Average receivables | 19.52B | 14.36B | 11.02B | 12.03B | 14.36B | |
Average payables | 10.28B | 8.57B | 7.27B | 6.76B | 5.95B | |
Average inventory | 11.73B | 9.28B | 7.01B | 7B | 6.47B | |
Days sales outstanding | 58.46 | 31.37 | 46.97 | 53.02 | 60.55 | |
Days payables outstanding | 26.59 | 23.69 | 26.44 | 25.91 | 18.22 | |
Days of inventory on hand | 30.79 | 23.52 | 24.64 | 29.49 | 18.6 | |
Receivables turnover | 1.54 | 2.87 | 1.92 | 1.7 | 1.49 | |
Payables turnover | 3.39 | 3.8 | 3.4 | 3.47 | 4.94 | |
Inventory turnover | 2.92 | 3.83 | 3.65 | 3.05 | 4.84 | |
ROE | -0.26 | 0.05 | -0.04 | -0.07 | 0.03 | |
Capex per share | -55 | -34.62 | -40.56 | -46.19 | -90.09 |
067630.KQ Frequently Asked Questions
What is HLB Life Science Co., Ltd. stock symbol ?
HLB Life Science Co., Ltd. is a KR stock and trading under the symbol 067630.KQ
What is HLB Life Science Co., Ltd. stock quote today ?
HLB Life Science Co., Ltd. stock price is $16270 today.
Is HLB Life Science Co., Ltd. stock public?
Yes, HLB Life Science Co., Ltd. is a publicly traded company.